Tel Aviv, Israel

Ofir Levi

This inventor holds 1 USPTO granted patent. Top assignee: Vallon Pharmaceuticals, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ofir Levi. Retrieved from https://idiyas.com/inventor/ofir-levi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ofir Levi - Innovator in Cognitive Impairment Treatment

Introduction

Ofir Levi is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of cognitive health through his innovative approaches to treatment.

Latest Patents

Ofir Levi holds a patent for "Compositions and methods of treating cognitive impairment." This invention focuses on a method of treating or alleviating cognitive impairment by administering an abuse-deterrent formulation containing dextroamphetamine sulfate. His work in this area is crucial for developing safer treatment options for cognitive issues.

Career Highlights

Ofir Levi is currently associated with Vallon Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His expertise in pharmacology and cognitive health has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Ofir has collaborated with notable colleagues, including Timothy Whitaker and David Baker. Their combined efforts contribute to the innovative environment at Vallon Pharmaceuticals, Inc.

Conclusion

Ofir Levi's work in treating cognitive impairment showcases his dedication to improving mental health through innovative solutions. His contributions are paving the way for advancements in cognitive treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…